Stocks To Buy Now

Blog


The Aristocrat Group Corp. (ASCC) to Increase Proven Marketing Activities in Canada to Grow Ultra-Premium Vodka Brand

The Aristocrat Group Corp. announced that it plans on launching RWB Ultra-Premium Handcrafted Vodka in Canada using the same marketing tactics that made the brand a success in the U.S.

Late last month, the company revealed that its joint venture partner in Canada, Westcoast Spirits Company, Ltd., had begun a campaign to promote RWB Vodka in British Columbia. The international market expansion is a major step forward for the brand.

After the product is picked up by Canadian distributors, the company will set up in-store promotional events featuring RWB-branded swag and complimentary tastings at British Columbia Liquor Board-operated outlets as well as independent distilled spirits stores. Future plans call for potential sponsorship of rising music stars and sporting events, too, just as the company has successfully done in the U.S.

“Canada is an important market for us, so we plan to invest heavily in RWB’s success in British Columbia in order to establish a foothold,” ASCC CEO Robert Federowicz said. “Thanks to our experience in the U.S. market, we know which promotions are most effective. We’ll be putting that knowledge to good use in Canada.”

Handcrafted, American-made RWB Ultra-Premium Handcrafted Vodka is made with the highest-quality, non-GMO Idaho potatoes and pure mountain spring water and then refined by a five-stage filtration system that produces a gluten-free high-class vodka without the high-class price. It is available online to U.S. consumers and at more than 60 retail locations and 250 clubs, bars and restaurants.

For more information, visit www.aristocratgroupcorp.com/investors

Let us hear your thoughts: The Aristocrat Group Corp. Message Board

From Our Blog

Regentis Biomaterials and the Shift from Symptom Management to Structural Repair in Knee Cartilage Care

September 28, 2026

For much of the last three decades, treatment of degenerative knee disease has centered heavily on managing symptoms with anti-inflammatories, activity modification, lubricants and injections, while structural intervention was often reserved for more advanced disease. Focal cartilage defects had surgical options, but those came with their own tradeoffs in durability, complexity, and cost. That balance […]

Rotate your device 90° to view site.